in this issue
Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Siegfried Posts Higher Earnings and Flat Sales
10:08 AM MDT | September 8, 2008 | Ian Young
Siegfried (Zofingen, Switzerland) posted a 33% increase in Ebit for the first half of this year, to SF28.5 million ($25.7million) on sales up 1%, to SF160 million. Earnings benefited from the sale of a pharmaceutical facility at Zofingen to Arena Pharmaceuticals (San Diego) and license payments for a previous biogeneric project. Second-quarter figures were not disclosed. Siegfried’s active ingredients division reported Ebit of SF1.7 million, “clearly lower than last year,” due partly to a one-time payment of SF9.1 million made by...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee